BMPR2 and pulmonary arterial hypertension: The role of epigenetic variation in PAH is intriguing, since BMPR2 promoter methylation is elevated in PAH individuals compared to unaffected BMPR2 mutation carriers5, offering one mechanism for the varying penetration of heritable PAH and a potential target for pharmacological intervention.